Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

21 Mar 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..